ANCA-associated vasculitis trials in Brazil
2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
- Where
- São Paulo
- Age
- 6 years to 17 years
- People
- 14 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06512883 · EU 2023-508533-14-00 - Phase 4Taking peopleSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Where
- São Paulo
- Age
- 12 years to 59 years
- People
- 477
- Run by
- University of Sao Paulo General Hospital
See details and how to joinNCT07087912